

Your body generates biological data every day.
We turn it into decisions to help you feel better
NostraBiome analyses your microbiome, genetic profile, integrates all your lab results and medical history, and builds a plan that adjusts constantly — guided by AI, with direct access to human experts.
Download the NostraBiome mobile app on your smartphone or from the web:
10 years
Cumulated research and studies embedded in our technology.
90%
of IBD patients get into full
sustained remission.
94%
of pediatric patients respond
in less than a month
52%
of oncology patients experienced reduced digestive side effects
Beyond today's standard of personalization
Before your recommendation is generated our technology considers:

Clinical studies
At NostraBiome, we are dedicated to advancing the understanding and treatment of complex medical conditions through rigorous clinical research. Our ongoing and planned studies focus on the pivotal role of the microbiome in diseases such as Inflammatory Bowel Disease (IBD) and cancer.
AI-driven microbiome modulation demonstrates significant improvements across diverse groups of IBD and oncology patients.

We detect the hidden
chemical causes of your disease
Your microbiome is the largest producer of chemical metabolites that interact with your immune and metabolic health.
We detect each patient's dynamic inflammatory microbiome signatures connected with their medical condition. We predict the impact load of the microbiome on the immune system and enhance the effectiveness of existing therapies

The signals we look at
Who we are
We are a health and technology company uniting scientific advancements, artificial intelligence, biology, genetics, and medicine.
Our mission is to harness microbiome insights as a key factor in enhancing therapies for inflammatory bowel disease, cancer, and oral health, significantly improving the efficacy of existing treatments and bringing hope to millions.
Endorsed by industry leaders
We believe advanced personalization and biology modulation will lead to a revolution in immunotherapy
We leverage AI, DNA testing, advanced data profiling, and applied science to accelerate the ability of patients worldwide to complement their therapies.
By doing so, we significantly enhance the likelihood of success for conditions where standard treatments have traditionally offered limited effectiveness, such as IBD, cancer, and autoimmune diseases.








